FutureChem Co Ltd
KOSDAQ:220100
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
FutureChem Co Ltd
Long-Term Debt
FutureChem Co Ltd
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Long-Term Debt
₩2.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Long-Term Debt
₩896.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Long-Term Debt
₩31m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Long-Term Debt
₩26.8B
|
CAGR 3-Years
589%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Long-Term Debt
₩929.2m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Long-Term Debt
₩1.7B
|
CAGR 3-Years
98%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
FutureChem Co Ltd
Glance View
FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
See Also
What is FutureChem Co Ltd's Long-Term Debt?
Long-Term Debt
2.1B
KRW
Based on the financial report for Sep 30, 2025, FutureChem Co Ltd's Long-Term Debt amounts to 2.1B KRW.
What is FutureChem Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-33%
Over the last year, the Long-Term Debt growth was -84%. The average annual Long-Term Debt growth rates for FutureChem Co Ltd have been -4% over the past three years , -33% over the past five years .
